CAW
AMAG

Cornerstone Advisors (Washington)’s AMAG Pharmaceuticals AMAG Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-206
Closed -$5K – 888
2016
Q1 		$5K Hold
206
– – 0.01% 578
2015
Q4 		$6K Hold
206
– – 0.01% 541
2015
Q3 		$8K Buy
+206
New +$12.8K 0.01% 492

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Cornerstone Advisors (Washington)'s AMAG Position: Q2 2016 in Review

Cornerstone Advisors (Washington) sold out of AMAG Pharmaceuticals (AMAG) in Q2 2016, closing a stake of 206 shares — an estimated $5K sold.

Cornerstone Advisors (Washington) first reported a position in AMAG in Q3 2015 and held it in 3 quarters. The position peaked at $8K in Q3 2015. 165 funds tracked by Wall St. Rank hold AMAG as of Q2 2016.

  • Cornerstone Advisors (Washington) reported no remaining AMAG Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 206 AMAG Pharmaceuticals shares in Q2 2016, an estimated $5K.
  • Cornerstone Advisors (Washington) first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Cornerstone Advisors (Washington)'s AMAG Pharmaceuticals position peaked at $8K in Q3 2015.
  • 165 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2016.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q2 2016, filed 25 Jul 2016.